Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.

Mette BrabrandKnud Nørregaard HansenChristian B LaursenThomas Stauffer LarsenHanne VestergaardNiels Abildgaard

Published in: European journal of haematology (2019)

In the largest study ever reported, we found a lower prevalence of PH (3.8%) than previously reported. Screening for PH in unselected MPN patients is not justified.

Keyphrases

pulmonary hypertension
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
risk factors
prognostic factors
pulmonary artery
pulmonary arterial hypertension
coronary artery
patient reported outcomes